FDA Must Update Court on Deadly Drug. Critics Have Low Expectations.

The pro-life movement has low expectations ahead of the deadline for the Food and Drug Administration to provide an update on its abortion pill safety review, leaders tell the Daily Signal. “I’m not expecting much,” Tom McClusky, director of government affairs at CatholicVote, told the Daily Signal. “I mean, everybody says, but nobody confirms, that...